查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1824398

2025年全球靜脈（IV）水合療法市場報告

Intravenous (IV) Hydration Therapy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

靜脈補液療法市場預計將在未來幾年強勁成長，2029年將達到43.9億美元，年複合成長率（CAGR）為9.6%。預測期內的成長可歸因於以消費者為中心的個人化服務、融入企業健康計畫、預防性健康措施、健身和健康旅遊的成長以及人口老化的需求。預測期內的主要趨勢包括符合道德規範和永續的採購、整體健康療養、補液酒吧和休息室，以及對心理健康的關注。

未來五年9.6%的成長預測比我們先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國診所的營運，導致從愛爾蘭和墨西哥進口的預混合料電解質溶液和靜脈注射的成本增加，脫水治療的可及性降低，並可能增加門診費用。由於互惠關稅以及貿易緊張局勢和限制措施的升級對全球經濟和貿易的負面影響，其影響可能會更加廣泛。

慢性病盛行率預計將激增，這將推動靜脈補液療法市場大幅成長。這種治療方法透過靜脈注射維生素和必需營養素，為與慢性病作鬥爭的人們提供顯著的能量補充。截至2022年9月，世界衛生組織（WHO）報告稱，全球每年有4,100萬人死於慢性病，佔全球非傳染性疾病（NCD）或慢性病死亡總數的74%。值得注意的是，心血管疾病造成1,790萬人死亡，癌症造成930萬人死亡，慢性呼吸道疾病造成410萬人死亡，糖尿病造成200萬人死亡。慢性病的增加是推動靜脈補液療法市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球靜脈（IV）水合療法：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球靜脈（IV）水合療法市場：成長率分析
  • 全球靜脈（IV）水合療法市場表現：規模與成長，2019-2024年
  • 全球靜脈 (IV) 水合療法市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球靜脈 (IV) 水合療法：總目標市場 (TAM)

第6章 市場細分

  • 全球靜脈 (IV) 水合療法市場：按服務、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 免疫增強劑
  • 能量助推器
  • 護膚
  • 偏頭痛
  • 其他服務
  • 全球靜脈（IV）水合療法市場：依成分、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 藥用
  • 非藥品
  • 全球靜脈 (IV) 水合療法市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 健康中心和水療中心
  • 家庭醫療保健
  • 其他最終用戶
  • 全球靜脈 (IV) 水合療法市場：按免疫增強劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 維生素C滴注
  • 鋅滴
  • 麩胺基硫輸注
  • 全球靜脈 (IV) 水合療法市場：按能量增強劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 維生素B複合物輸液
  • 胺基酸輸注
  • 電解質溶液
  • 全球靜脈 (IV) 水合療法市場：按護膚類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 水合注射
  • 抗衰老注射
  • 排毒輸液
  • 全球靜脈 (IV) 水合療法市場：按偏頭痛類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 止痛點滴
  • 鎂滴
  • 水合注射
  • 全球靜脈 (IV) 水合療法市場：按其他服務細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 宿醉緩解液
  • 減重點滴
  • 運動表現注入

第7章 區域和國家分析

  • 全球靜脈（IV）水合療法市場：區域分析、預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球靜脈 (IV) 水合療法市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 靜脈（IV）水合療法市場：競爭格局
  • 靜脈（IV）水合療法市場：公司簡介
    • Revitalist Overview, Products and Services, Strategy and Financial Analysis
    • JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
    • NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Liquid IV
  • Medtronic Plc.
  • Drip Hydration
  • Amanta Healthcare Ltd.
  • Becton Dickinson and Company
  • Elixir
  • Baxter International Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Sippex IV bag
  • REVIV
  • Braun Melsungen AG
  • The IV Doc Inc.
  • Terumo Medical Corporation
  • Grifols SA
  • Harpal Clinic Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年靜脈補液療法市場：提供新機會的國家
  • 2029年靜脈補液療法市場：細分領域帶來新機會
  • 靜脈（IV）水合療法市場2029年：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25046u

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (iv) hydration therapy market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to medical treatments and procedures, athletic and sports performance, clinical management of dehydration, recovery from illnesses, and mobile and concierge services.

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to consumer-centric personalization, integration into corporate wellness programs, preventive health measures, growth in fitness and wellness tourism, and aging population demands. Major trends in the forecast period include ethical and sustainable sourcing, holistic health retreats, hydration bars and lounges, and a focus on mental wellness.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. clinics by increasing costs for pre-mixed electrolyte solutions and IV administration sets imported from Ireland and Mexico, potentially reducing access to dehydration treatments and raising outpatient care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (IV) hydration therapy market include Revitalist, JW Life Science Corporation, NextGen Healthcare, Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG

North America was the largest region in the intravenous (IV) hydration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Service: Immune Boosters; Energy Boosters; Skin Care; Migraine; Other Service
  • 2) By Component: Medicated; Non-Medicated
  • 3) By End-User: Hospitals And Clinics; Wellness Centers And Spas; Home Healthcare; Other End-Users
  • Subsegments:
  • 1) By Immune Boosters: Vitamin C Infusion; Zinc Infusion; Glutathione Infusion
  • 2) By Energy Boosters: B-Complex Vitamins Infusion; Amino Acids Infusion; Electrolyte Solutions
  • 3) By Skin Care: Hydration Infusion; Anti-Aging Infusion; Detox Infusion
  • 4) By Migraine: Pain Relief Infusion; Magnesium Infusion; Hydration Infusion
  • 5) By Other Services: Hangover Relief Infusion; Weight Loss Infusion; Athletic Performance Infusion
  • Companies Mentioned: Revitalist; JW Life Science Corporation; NextGen Healthcare; Pfizer Inc.; Fresenius Kabi AG; Liquid IV; Medtronic Plc.; Drip Hydration; Amanta Healthcare Ltd.; Becton Dickinson and Company; Elixir; Baxter International Inc.; Otsuka Pharmaceutical Co. Ltd.; Sippex IV bag; REVIV; Braun Melsungen AG; The IV Doc Inc.; Terumo Medical Corporation; Grifols S.A.; Harpal Clinic Ltd.; Fosmo Med; Core IV Therapy LLC; Cryojuvenate UK Ltd.; Hospira; Teleflex Incorporated; Sichuan Kelun Pharmaceutical Co.Ltd.; ICU Medical Inc.; Vygon SAS; Vifor Pharma Management AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Intravenous (IV) Hydration Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Intravenous (IV) Hydration Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Intravenous (IV) Hydration Therapy Market Growth Rate Analysis
  • 5.4. Global Intravenous (IV) Hydration Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Intravenous (IV) Hydration Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Intravenous (IV) Hydration Therapy Total Addressable Market (TAM)

6. Intravenous (IV) Hydration Therapy Market Segmentation

  • 6.1. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Other Service
  • 6.2. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medicated
  • Non-Medicated
  • 6.3. Global Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Wellness Centers And Spas
  • Home Healthcare
  • Other End-Users
  • 6.4. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Immune Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Vitamin C Infusion
  • Zinc Infusion
  • Glutathione Infusion
  • 6.5. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Energy Boosters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • B-Complex Vitamins Infusion
  • Amino Acids Infusion
  • Electrolyte Solutions
  • 6.6. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Skin Care, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydration Infusion
  • Anti-Aging Infusion
  • Detox Infusion
  • 6.7. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Migraine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Relief Infusion
  • Magnesium Infusion
  • Hydration Infusion
  • 6.8. Global Intravenous (IV) Hydration Therapy Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hangover Relief Infusion
  • Weight Loss Infusion
  • Athletic Performance Infusion

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

  • 7.1. Global Intravenous (IV) Hydration Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Intravenous (IV) Hydration Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

  • 8.1. Asia-Pacific Intravenous (IV) Hydration Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Intravenous (IV) Hydration Therapy Market

  • 9.1. China Intravenous (IV) Hydration Therapy Market Overview
  • 9.2. China Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Intravenous (IV) Hydration Therapy Market

  • 10.1. India Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Intravenous (IV) Hydration Therapy Market

  • 11.1. Japan Intravenous (IV) Hydration Therapy Market Overview
  • 11.2. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Intravenous (IV) Hydration Therapy Market

  • 12.1. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Intravenous (IV) Hydration Therapy Market

  • 13.1. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Intravenous (IV) Hydration Therapy Market

  • 14.1. South Korea Intravenous (IV) Hydration Therapy Market Overview
  • 14.2. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Intravenous (IV) Hydration Therapy Market

  • 15.1. Western Europe Intravenous (IV) Hydration Therapy Market Overview
  • 15.2. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Intravenous (IV) Hydration Therapy Market

  • 16.1. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Intravenous (IV) Hydration Therapy Market

  • 17.1. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Intravenous (IV) Hydration Therapy Market

  • 18.1. France Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Intravenous (IV) Hydration Therapy Market

  • 19.1. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Intravenous (IV) Hydration Therapy Market

  • 20.1. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

  • 21.1. Eastern Europe Intravenous (IV) Hydration Therapy Market Overview
  • 21.2. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Intravenous (IV) Hydration Therapy Market

  • 22.1. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Intravenous (IV) Hydration Therapy Market

  • 23.1. North America Intravenous (IV) Hydration Therapy Market Overview
  • 23.2. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Intravenous (IV) Hydration Therapy Market

  • 24.1. USA Intravenous (IV) Hydration Therapy Market Overview
  • 24.2. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Intravenous (IV) Hydration Therapy Market

  • 25.1. Canada Intravenous (IV) Hydration Therapy Market Overview
  • 25.2. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Intravenous (IV) Hydration Therapy Market

  • 26.1. South America Intravenous (IV) Hydration Therapy Market Overview
  • 26.2. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Intravenous (IV) Hydration Therapy Market

  • 27.1. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Intravenous (IV) Hydration Therapy Market

  • 28.1. Middle East Intravenous (IV) Hydration Therapy Market Overview
  • 28.2. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Intravenous (IV) Hydration Therapy Market

  • 29.1. Africa Intravenous (IV) Hydration Therapy Market Overview
  • 29.2. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Intravenous (IV) Hydration Therapy Market Competitive Landscape
  • 30.2. Intravenous (IV) Hydration Therapy Market Company Profiles
    • 30.2.1. Revitalist Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. JW Life Science Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. NextGen Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

  • 31.1. Liquid IV
  • 31.2. Medtronic Plc.
  • 31.3. Drip Hydration
  • 31.4. Amanta Healthcare Ltd.
  • 31.5. Becton Dickinson and Company
  • 31.6. Elixir
  • 31.7. Baxter International Inc.
  • 31.8. Otsuka Pharmaceutical Co. Ltd.
  • 31.9. Sippex IV bag
  • 31.10. REVIV
  • 31.11. Braun Melsungen AG
  • 31.12. The IV Doc Inc.
  • 31.13. Terumo Medical Corporation
  • 31.14. Grifols S.A.
  • 31.15. Harpal Clinic Ltd.

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

34. Recent Developments In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Intravenous (IV) Hydration Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Intravenous (IV) Hydration Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Intravenous (IV) Hydration Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer